Investigation of the role of the ras protooncogene point mutation in human uveal melanomas.

Daniel Albert // Publications // Jun 01 1993

PubMed ID: 8505202

Author(s): Soparker CN, O’Brien JM, Albert DM. Investigation of the role of the ras protooncogene point mutation in human uveal melanomas. Invest Ophthalmol Vis Sci. 1993 Jun;34(7):2203-9. PMID 8505202

Journal: Investigative Ophthalmology & Visual Science, Volume 34, Issue 7, Jun 1993

PURPOSE Genetic alterations have been observed in a wide variety of neoplastic processes, including Burkitt’s lymphoma, chronic myelogenous leukemia, promyelocytic leukemia, and solid tumors of the colon, skin, and breast. The polymerase chain reaction (PCR), dot blotting, and direct double-stranded DNA sequencing were used to assess ras gene activation in human uveal melanomas for three candidate genes: c-Ha-ras1, c-Ki-ras2, and N-ras at codons 12, 13, and 61.

METHODS Samples of 49 human uveal melanomas were obtained. Amplifiable high molecular weight DNA was obtained from 39 of these. PCR amplification of regions centering on three candidate ras genes was performed. PCR-amplified DNA was evaluated by dot blot and double-stranded DNA sequencing utilizing standard methods.

RESULTS No point mutations were identified in screening the c-Ha-ras gene nor were any genetic alterations found in the c-Ki-ras2 gene at codons 12 and 13. Only wild-type sequences were found at codon 61. No ras mutations were detected in any uveal melanomas studied.

CONCLUSIONS This study provides no evidence to support an association between ras protooncogene mutations and human uveal melanomas at codons 12, 13, or 61.